Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01099020 · ClinicalTrials.gov registry record
Temporal Pattern of Circulating DNA for Patients Receiving Irradiation
A clinical trial, sponsored by University of Rochester.
- Terminated
- Registry status
- 13
- Enrollment target
NCT01099020: Clinical Trial study, sponsored by University of Rochester.
NCT01099020 is a clinical trial that was terminated before completion, run by University of Rochester. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01099020 was terminated before completion, sponsored by University of Rochester.
- TERMINATED
- Registry status
- 13 participants
- Enrollment target
Study Summary
The purpose of the research study is to test a measurement tool that will determine the radiation dose people receive when they have been accidentally exposed to radiation. This test will be done using a small amount of blood and known dose of radiation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2010-04 |
| Est. Completion | 2011-12 |
Why NCT01099020 stopped before completion
NCT01099020 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01099020 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01099020 about?
NCT01099020 is a clinical study titled "Temporal Pattern of Circulating DNA for Patients Receiving Irradiation". The purpose of the research study is to test a measurement tool that will determine the radiation dose people receive when they have been accidentally exposed to radiation. This test will be done using a small amount of blood and known dose of radiation.
What is the current status of trial NCT01099020?
This trial is currently terminated. The enrollment target is 13 participants. The study started on 2010-04. Estimated completion is 2011-12.
Who is sponsoring clinical trial NCT01099020?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia